US approval for treatment of skin cancer
Pharmaceutical group Sanofi announced on Wednesday that the US Medicines Agency (FDA) had approved its drug Libtayo for the treatment of advanced skin cancer, in a statement. “Libtayo Receives Full Approval in Locally Advanced Basal Cell Carcinoma (CBC) and Expedited Approval in Metastatic CBC, Following Priority Review by Food and Drug Administration“(FDA) in the United … Read more